A Neutralizing Antibody Recognizing Primarily N-Linked Glycan Targets the Silent Face of the HIV Envelope.
Zhou, Tongqing; Zheng, Anqi; Baxa, Ulrich; Chuang, Gwo-Yu; Georgiev, Ivelin S; Kong, Rui; O'Dell, Sijy; Shahzad-Ul-Hussan, Syed; Shen, Chen-Hsiang; Tsybovsky, Yaroslav; Bailer, Robert T; Gift, Syna K; Louder, Mark K; McKee, Krisha; Rawi, Reda; Stevenson, Catherine H; Stewart-Jones, Guillaume B E; Taft, Justin D; Waltari, Eric; Yang, Yongping; Zhang, Baoshan; Shivatare, Sachin S; Shivatare, Vidya S; Lee, Chang-Chun D; Wu, Chung-Yi; Mullikin, James C; Bewley, Carole A; Burton, Dennis R; Polonis, Victoria R; Shapiro, Lawrence; Wong, Chi-Huey; Mascola, John R; Kwong, Peter D; Wu, Xueling.
; 48(3): 500-513.e6, 2018 03 20.
Artigo em Inglês | MEDLINE | ID: mdl-29548671
Intra-spike crosslinking overcomes antibody evasion by HIV-1.
Structural evolution of glycan recognition by a family of potent HIV antibodies.
Playing Chess with HIV.
Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization.
HIV Broadly Neutralizing Antibodies: Taking Good Care Of The 98.
Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody.
Structural insights on the role of antibodies in HIV-1 vaccine and therapy.
The role of antibodies in HIV vaccines.
HIV Envelope Glycoform Heterogeneity and Localized Diversity Govern the Initiation and Maturation of a V2 Apex Broadly Neutralizing Antibody Lineage.
HIV-1 Neutralizing Antibodies with Limited Hypermutation from an Infant.